| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |